Legend Biotech (LEGN) Times Interest Earned (2019 - 2026)

Legend Biotech (LEGN) has 8 years of Times Interest Earned data on file, last reported at -$9.05 in Q1 2026.

• Quarterly Times Interest Earned rose 10.68% year-over-year to -$9.05 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$16.41 (down 107.2% YoY) and the FY2025 annual result came in at $6.38, up 144.55% from the prior year.
• Times Interest Earned slipped to -$9.05 in Q1 2026, from $3.58 in the prior quarter.
• In the past five years, Times Interest Earned ranged from a high of $32.47 in Q1 2024 to a low of -$13.6 million in Q4 2023.
• A 5-year average of -$802832.0 and a median of -$6.72 in 2023 frame the typical range for Times Interest Earned.
• Annual changes were most pronounced in 2022 — Times Interest Earned surged 2232.99% — and 2023, when it tumbled 59178890.36%.
• Tracing LEGN's Times Interest Earned over 5 years: stood at -$23.06 in 2022, then plunged by 59178890.36% to -$13.6 million in 2023, then soared by 100.0% to $15.25 in 2024, then slumped by 76.51% to $3.58 in 2025, then slumped by 352.79% to -$9.05 in 2026.
• The last three Times Interest Earned figures came in at -$9.05 (Q1 2026), $3.58 (Q4 2025), and $7.71 (Q3 2025), per Business Quant data.